These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 8841148)
1. Pharmacokinetic and pharmacodynamic interactions between diltiazem and quinidine. Laganière S; Davies RF; Carignan G; Foris K; Goernert L; Carrier K; Pereira C; McGilveray I Clin Pharmacol Ther; 1996 Sep; 60(3):255-64. PubMed ID: 8841148 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers. Booker BM; Magee MH; Blum RA; Lates CD; Jusko WJ Clin Pharmacol Ther; 2002 Oct; 72(4):370-82. PubMed ID: 12386639 [TBL] [Abstract][Full Text] [Related]
3. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure. Mahgoub AA; El-Medany AH; Abdulatif AS Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic interactions of nifedipine and quinidine. Hippius M; Henschel L; Sigusch H; Tepper J; Brendel E; Hoffmann A Pharmazie; 1995 Sep; 50(9):613-6. PubMed ID: 7480098 [TBL] [Abstract][Full Text] [Related]
5. The interaction of diltiazem with lovastatin and pravastatin. Azie NE; Brater DC; Becker PA; Jones DR; Hall SD Clin Pharmacol Ther; 1998 Oct; 64(4):369-77. PubMed ID: 9797793 [TBL] [Abstract][Full Text] [Related]
6. Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers. Christensen H; Asberg A; Holmboe AB; Berg KJ Eur J Clin Pharmacol; 2002 Nov; 58(8):515-20. PubMed ID: 12451428 [TBL] [Abstract][Full Text] [Related]
7. Greater quinidine-induced QTc interval prolongation in women. Benton RE; Sale M; Flockhart DA; Woosley RL Clin Pharmacol Ther; 2000 Apr; 67(4):413-8. PubMed ID: 10801251 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic interactions between simvastatin and diltiazem in patients with hypercholesterolemia and hypertension. Watanabe H; Kosuge K; Nishio S; Yamada H; Uchida S; Satoh H; Hayashi H; Ishizaki T; Ohashi K Life Sci; 2004 Dec; 76(3):281-92. PubMed ID: 15531380 [TBL] [Abstract][Full Text] [Related]
9. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine. Kharasch ED; Hoffer C; Whittington D; Sheffels P Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457 [TBL] [Abstract][Full Text] [Related]
10. Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone. Varis T; Backman JT; Kivistö KT; Neuvonen PJ Clin Pharmacol Ther; 2000 Mar; 67(3):215-21. PubMed ID: 10741623 [TBL] [Abstract][Full Text] [Related]
11. Effects of verapamil and diltiazem on the pharmacokinetics and pharmacodynamics of buspirone. Lamberg TS; Kivistö KT; Neuvonen PJ Clin Pharmacol Ther; 1998 Jun; 63(6):640-5. PubMed ID: 9663178 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interactions of moricizine and diltiazem in healthy volunteers. Shum L; Pieniaszek HJ; Robinson CA; Davidson AF; Widner PJ; Benedek IH; Flamenbaum W J Clin Pharmacol; 1996 Dec; 36(12):1161-8. PubMed ID: 9013374 [TBL] [Abstract][Full Text] [Related]
13. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers. Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615 [TBL] [Abstract][Full Text] [Related]
14. Bioequivalence and relative bioavailability of a new diltiazem sustained release formulation. Scheiwe MW; Lankhaar G; Kleinbloesem CH Arzneimittelforschung; 1996 Oct; 46(10):960-3. PubMed ID: 8931888 [TBL] [Abstract][Full Text] [Related]
15. PK/PD modelling of high-dose diltiazem--absorption-rate dependency of the hysteresis loop. Luckow V; Della Paschoa O Int J Clin Pharmacol Ther; 1997 Oct; 35(10):418-25. PubMed ID: 9352390 [TBL] [Abstract][Full Text] [Related]
16. Effect of diltiazem on the pharmacokinetics of MPC-1304, a new calcium channel blocker. Ohashi K; Sudo T; Sakamoto K; Tateishi T; Fujimura A; Kumagai Y; Shiga T; Ebihara A Int J Clin Pharmacol Ther Toxicol; 1992 Aug; 30(8):271-4. PubMed ID: 1526689 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers. Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765 [TBL] [Abstract][Full Text] [Related]
18. Further elucidation of pharmacokinetic interaction between diltiazem and warfarin. Stoysich AM; Lucas BD; Mohiuddin SM; Hilleman DE Int J Clin Pharmacol Ther; 1996 Feb; 34(2):56-60. PubMed ID: 8929747 [TBL] [Abstract][Full Text] [Related]
19. Determination of the interaction of 3S-hydroxy-10,11-dihydroquinidine on the pharmacokinetics and pharmacodynamics of warfarin. Trenk D; Möhrke W; Warth L; Jähnchen E Arzneimittelforschung; 1993 Aug; 43(8):836-41. PubMed ID: 8216438 [TBL] [Abstract][Full Text] [Related]
20. The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans. Capon DA; Bochner F; Kerry N; Mikus G; Danz C; Somogyi AA Clin Pharmacol Ther; 1996 Sep; 60(3):295-307. PubMed ID: 8841152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]